Cancer patient aggressive. Cancer Treatment: Chemotherapy papilloma virus contagioso
Conținutul Abstract Cancer patient aggressive, adoption of novel drugs for systemic treatment of metastatic prostate cancer term aggressive has led to a striking improvement of response rate and survival in both hormone-sensitive and castration-resistant disease.
In most cancer term aggressive, prostate cancer essentially depends on androgen receptor cancer patient aggressive axis, even in castration-resistant setting, and hence may be targeted by second generation hormonal therapy.
However, a subset of patients bears androgen-independent cancer biology with a short-term response to hormonal treatment, early and extensive visceral metastases, low PSA levels and poor outcomes. Identification and specific management of these rapidly cancer patient aggressive malignancies is of an unmet cancer term aggressive need since their classification and utilized therapeutic regimens vary significantly.
Unfortunately, molecular pathways have not been sufficiently elucidated yet in order to provide an effective targeted treatment with a prolonged response.
Lack of diagnostic and predictive biomarkers for these cancers makes successful counteractions against them even more sophisticated. In this comprehensive review, we cancer term aggressive at summarizing the current body of literature reporting on causal molecular machinery as well as diagnostic and therapeutic concepts of aggressive prostate tumors and draw clinically relevant conclusions for the up-to-date sensible disease management.